Search results for "Diabetes and Endocrinology"

showing 10 items of 12 documents

Thirty-one novel biomarkers as predictors for clinically incident diabetes.

2010

Background The prevalence of diabetes is increasing in all industrialized countries and its prevention has become a public health priority. However, the predictors of diabetes risk are insufficiently understood. We evaluated, whether 31 novel biomarkers could help to predict the risk of incident diabetes. Methods and Findings The biomarkers were evaluated primarily in the FINRISK97 cohort (n = 7,827; 417 cases of clinically incident diabetes during the follow-up). The findings were replicated in the Health 2000 cohort (n = 4,977; 179 cases of clinically incident diabetes during the follow-up). We used Cox proportional hazards models to calculate the relative risk of diabetes, after adjustin…

AdultMaleRiskmedicine.medical_specialtyDiabetes riskPublic Health and Epidemiologylcsh:Medicine030209 endocrinology & metabolism030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineSex FactorsPredictive Value of TestsDiabetes mellitusInternal medicinemedicineDiabetes MellitusHumansCardiovascular Disorders/Vascular Biologylcsh:ScienceAgedApolipoproteins BProportional Hazards ModelsMultidisciplinaryAdiponectinbiologyProportional hazards modelbusiness.industrylcsh:RC-reactive proteinMiddle Agedmedicine.disease3. Good healthDiabetes and EndocrinologyC-Reactive ProteinROC CurveRelative riskImmunologyCohortFerritinsbiology.proteinlcsh:QFemaleAdiponectinbusinessBiomarkersCohort studyResearch ArticlePloS one
researchProduct

Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation.

2010

BACKGROUND: Exercise is an extreme physiological challenge for skeletal muscle energy metabolism and has notable health benefits. We aimed to identify and characterize metabolites, which are components of the regulatory network mediating the beneficial metabolic adaptation to exercise. METHODOLOGY AND PRINCIPAL FINDINGS: First, we investigated plasma from healthy human subjects who completed two independent running studies under moderate, predominantly aerobic conditions. Samples obtained prior to and immediately after running and then 3 and 24 h into the recovery phase were analyzed by a non-targeted (NT-) metabolomics approach applying liquid chromatography-qTOF-mass spectrometry. Under t…

AdultMalemedicine.medical_specialtyMagnetic Resonance SpectroscopyMetaboliteMuscle Fibers Skeletallcsh:MedicineBiologyIn Vitro TechniquesMass SpectrometryPhysiology/Muscle and Connective Tissuechemistry.chemical_compoundMiceMetabolomicsLipid oxidationInternal medicineCarnitinemedicineAnimalsHumansChemistry/BiochemistryCarnitineExercise physiologyMuscle Skeletallcsh:ScienceBeta oxidationExerciseCells CulturedChromatography High Pressure LiquidMultidisciplinaryReverse Transcriptase Polymerase Chain Reactionlcsh:RSkeletal muscleLipid metabolismLipid MetabolismDiabetes and EndocrinologyEndocrinologymedicine.anatomical_structurechemistryBiochemistry/Small Molecule ChemistryPublic Health and Epidemiology/Preventive Medicinelcsh:QPublic Health and Epidemiology/Exercise and SportsOxidation-Reductionmedicine.drugResearch ArticlePLoS ONE
researchProduct

Elevated peripheral visfatin levels in narcoleptic patients.

2008

OBJECTIVE: Narcolepsy is a severe sleep disorder that is characterized by excessive daytime sleepiness, cataplexies and a tendency towards obesity. Recent discoveries indicate that the major pathophysiology is a loss of hypocretin (orexin) producing neurons due to immunologically mediated degeneration. Visfatin is a recently described proinflammatory adipokine. It is identical to the immune modulating pre-B-cell colony enhancing factor (PBEF). Our study examines the hypothesis that visfatin levels are altered in narcoleptic patients. METHODS: For the analysis, a total of n = 54 patients (n = 18 males and n = 36 females) with the diagnosis of narcolepsy according to DSM-IV and the Internatio…

AdultMalemedicine.medical_specialtyPolysomnographyNicotinamide phosphoribosyltransferaseAdipokineExcessive daytime sleepinesslcsh:MedicinePolysomnographyBody Mass IndexProinflammatory cytokineDiabetes and Endocrinology/Obesitychemistry.chemical_compoundReference ValuesInternal medicinemedicineHumansHLA-DR2 AntigenAge of OnsetNicotinamide Phosphoribosyltransferaselcsh:ScienceAgedNarcolepsySleep disorderMultidisciplinarymedicine.diagnostic_testbusiness.industrylcsh:RMiddle Agedmedicine.diseaseOrexinEndocrinologyMental Health/Sleep Disordersnervous systemchemistryImmunologyCytokinesFemalelcsh:Qmedicine.symptomImmunology/Genetics of the Immune SystembusinessResearch ArticleNarcolepsyPLoS ONE
researchProduct

Association of Birth Weight With Type 2 Diabetes and Glycemic Traits: A Mendelian Randomization Study.

2019

Key Points Question Is birth weight associated with type 2 diabetes and glycemic traits? Findings This mendelian randomization study found that a 1-SD decrease in birth weight due to the genetic risk score was associated with a higher risk of type 2 diabetes among European and East Asian populations. In addition, a 1-SD decrease in birth weight was associated with a 0.189-SD increase in fasting glucose concentration, but not with fasting insulin, 2-hour glucose, or hemoglobin A1c level. Meaning A genetic predisposition to lower birth weight was associated with an increased risk of type 2 diabetes and increased fasting glucose, suggesting potential mechanisms through which perturbation of th…

Blood GlucoseMaleType 2 diabetes0302 clinical medicineOdds RatioBirth WeightInsulin030212 general & internal medicineOriginal Investigation0303 health sciencesAsia EasternMendelian Randomization AnalysisGeneral MedicineMiddle Aged16. Peace & justice3. Good healthOnline OnlyDiabetes and EndocrinologyFemaletype 2 diabetesAdultmedicine.medical_specialtyDiabetes riskAdolescentBirth weightPolymorphism Single NucleotideWhite People03 medical and health sciencesYoung AdultSDG 3 - Good Health and Well-beingAsian PeopleDiabetes mellitusInternal medicineMendelian randomizationmedicineHumans030304 developmental biologyGlycemicAgedGlycated Hemoglobinbusiness.industryResearchInfant Newbornbirth weightGenetic VariationOdds ratioMendelian Randomization Analysismedicine.diseaseDiabetes Mellitus Type 2mendelian randomization studybusinessJAMA network open
researchProduct

Differences in muscle and adipose tissue gene expression and cardio-metabolic risk factors in the members of physical activity discordant twin pairs

2010

High physical activity/aerobic fitness predicts low morbidity and mortality. Our aim was to identify the most up-regulated gene sets related to long-term physical activity vs. inactivity in skeletal muscle and adipose tissues and to obtain further information about their link with cardio-metabolic risk factors. We studied ten same-sex twin pairs (age range 50-74 years) who had been discordant for leisure-time physical activity for 30 years. The examinations included biopsies from m. vastus lateralis and abdominal subcutaneous adipose tissue. RNA was analyzed with the genome-wide Illumina Human WG-6 v3.0 Expression BeadChip. For pathway analysis we used Gene Set Enrichment Analysis utilizing…

MaleSELECTIONFITNESSTwinsAdipose tissuephysical activityliikuntaPhysiology/Muscle and Connective TissueDiabetes and Endocrinology/ObesityCohort Studieschemistry.chemical_compound0302 clinical medicineRisk FactorsAdipocyte311 Basic medicinegeeniekspressioFinlandRegulation of gene expression0303 health sciencesINSULIN-RESISTANCEMultidisciplinaryQRGenetics and Genomics/Gene ExpressionMiddle Agedgeenien ilmentyminen3. Good healthmedicine.anatomical_structureTRIACYLGLYCEROLAdipose Tissue/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingMedicineSKELETAL-MUSCLEFemalePublic Health and Epidemiology/Exercise and SportsResearch ArticleMuscle tissuemedicine.medical_specialtyHeart DiseasesCardiovascular DisordersScience030209 endocrinology & metabolismEXERCISEMotor ActivityBiologyCAPACITY03 medical and health sciencesInsulin resistanceSDG 3 - Good Health and Well-beingInternal medicinemetaboliamedicineHumansAerobic exerciseMuscle SkeletalCell Biology/Gene ExpressionAged030304 developmental biologymatebolismMORTALITYCholesterol HDLSkeletal muscleLipid metabolismLipid Metabolismmedicine.diseasekaksosetEndocrinologyGene Expression RegulationchemistryADAPTATIONSCHRONIC DISEASEEnergy MetabolismPLoS ONE
researchProduct

Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve ga…

2019

IntroductionBariatric surgery is increasingly recognised as an effective treatment option for subjects with type 2 diabetes and obesity; however, there is no conclusive evidence on the superiority of Roux-en-Y gastric bypass or sleeve gastrectomy. The Oseberg study was designed to compare the effects of gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function.Methods and analysisSingle-centre, randomised, triple-blinded, two-armed superiority trial carried out at the Morbid Obesity Centre at Vestfold Hospital Trust in Norway. Eligible patients with type 2 diabetes and obesity were randomly allocated in a 1:1 ratio to either gastric bypass or sleeve gastrecto…

Malemedicine.medical_specialtySleeve gastrectomyβ-cell functionmedicine.medical_treatment1843Gastric BypassBariatric Surgery030209 endocrinology & metabolismType 2 diabeteslaw.invention03 medical and health sciences0302 clinical medicineSuperiority TrialRandomized controlled trialClinical ProtocolslawGastrectomyDiabetes mellitusInternal medicineInsulin-Secreting CellsmedicineProtocolHumans030212 general & internal medicine1506VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771Glycated Hemoglobinbusiness.industryNorwayGeneral Medicinemedicine.diseaseRoux-en-Y anastomosismorbid obesityObesity MorbidDiabetes and EndocrinologyTreatment OutcomeDiabetes Mellitus Type 2GastrectomyFemaleLaparoscopytype 2 diabetesbusinessEpidemiologic MethodsBody mass indexrandomised controlled trialsleeve gastrectomy
researchProduct

Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study.

2008

Exposure to nicotine during smoking causes a multitude of metabolic changes that are poorly understood. We quantified and analyzed 198 metabolites in 283 serum samples from the human cohort KORA (Cooperative Health Research in the Region of Augsburg). Multivariate analysis of metabolic profiles revealed that the group of smokers could be clearly differentiated from the groups of former smokers and non-smokers. Moreover, 23 lipid metabolites were identified as nicotine-dependent biomarkers. The levels of these biomarkers are all up-regulated in smokers compared to those in former and non-smokers, except for three acyl-alkyl-phosphatidylcholines (e.g. plasmalogens). Consistently significant r…

Nicotinemedicine.medical_specialtyPublic Health and Epidemiology/Environmental HealthMetabolitelcsh:MedicineBiologyPharmacologyCohort StudiesNicotinechemistry.chemical_compoundInternal medicineDiabetes and Endocrinology/EndocrinologyGene expressionmedicineMetabolomeCluster AnalysisHumansAlkylglycerone-phosphate synthaselcsh:Sciencechemistry.chemical_classificationAlkyl and Aryl TransferasesMultidisciplinarySmokinglcsh:RLipid metabolismPublic Health and Epidemiology/Global HealthChemical Biology/Small Molecule ChemistryEnzymeEndocrinologychemistryBiochemistry/Small Molecule ChemistryGlycerophospholipidMetabolomePhosphatidylcholineslcsh:Qbiology.geneMental Health/Personality DisordersBiomarkersResearch Articlemedicine.drugPLoS ONE
researchProduct

In Vitro Identification and Characterization of CD133pos Cancer Stem-Like Cells in Anaplastic Thyroid Carcinoma Cell Lines

2008

BackgroundRecent publications suggest that neoplastic initiation and growth are dependent on a small subset of cells, termed cancer stem cells (CSCs). Anaplastic Thyroid Carcinoma (ATC) is a very aggressive solid tumor with poor prognosis, characterized by high dedifferentiation. The existence of CSCs might account for the heterogeneity of ATC lesions. CD133 has been identified as a stem cell marker for normal and cancerous tissues, although its biological function remains unknown.Methodology/principal findingsATC cell lines ARO, KAT-4, KAT-18 and FRO were analyzed for CD133 expression. Flow cytometry showed CD133(pos) cells only in ARO and KAT-4 (64+/-9% and 57+/-12%, respectively). These …

Pathologymedicine.medical_specialtySciencemedicine.medical_treatmentThyroid Nuclear Factor 1Cell Culture TechniquesAntineoplastic AgentsCell SeparationStem cell markerDiabetes and Endocrinology/ThyroidSettore MED/13 - EndocrinologiaAntigens CDThyroid peroxidaseCancer stem cellCell Line TumorBiomarkers TumormedicineHumansANAPLASTIC THYROID CARCINOMA CANCER STEM CELLS CD133AC133 AntigenThyroid NeoplasmsGenetics and Genomics/Cancer GeneticsThyroid cancerTumor Stem Cell AssayCell ProliferationGlycoproteinsOncology/Head and Neck CancersMultidisciplinarybiologyCell growthQCarcinomaRNuclear ProteinsTumor Stem Cell Assaymedicine.diseaseFibronectinsembryonic structuresNeoplastic Stem CellsCancer researchbiology.proteinMedicineThyroglobulinStem cellPeptidesTranscription FactorsResearch ArticlePLoS ONE
researchProduct

Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo

2010

BACKGROUND: Hyperglycemia is acknowledged as an independent risk factor for developing diabetes-associated atherosclerosis. At present, most therapeutic approaches are targeted at a tight glycemic control in diabetic patients, although this fails to prevent macrovascular complications of the disease. Indeed, it remains highly controversial whether or not the mere elevation of extracellular D-glucose can directly promote vascular inflammation, which favors early pro-atherosclerotic events. METHODS AND FINDINGS: In the present work, increasing extracellular D-glucose from 5.5 to 22 mmol/L was neither sufficient to induce intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion mo…

Umbilical VeinsEndotheliumCardiovascular Disorders/Coronary Artery Diseaselcsh:MedicineInflammationIn vivoDiabetes mellitusCell AdhesionmedicineExtracellularAnimalsHumansLeukocyte RollingCardiovascular Disorders/Vascular BiologyUNESCO::CIENCIAS DE LA VIDA::Microbiología ::Otraslcsh:ScienceCell adhesionInflammationMultidisciplinaryInflammation; Pro-adhesive properties; High extracellular D-glucose; Human endothelial cells In Vitro; Rat microvessels In VivoDose-Response Relationship DrugChemistrylcsh:RCardiovascular Disorders/Peripheral Vascular DiseaseAdhesivenessEndothelial CellsChemotaxismedicine.diseaseIn vitroRatsChemotaxis LeukocyteDiabetes and EndocrinologyCell Biology/Cell AdhesionGlucosemedicine.anatomical_structureHyperglycemiaMicrovesselsImmunologyCancer researchlcsh:QEndothelium Vascularmedicine.symptomResearch Article
researchProduct

Chlamydia trachomatis Infection and Anti-Hsp60 Immunity: The Two Sides of the Coin

2009

Chlamydia trachomatis (CT) infection is one of the most common causes of reproductive tract diseases and infertility. CT-Hsp60 is synthesized during infection and is released in the bloodstream. As a consequence, immune cells will produce anti-CT-Hsp60 antibodies. Hsp60, a ubiquitous and evolutionarily conserved chaperonin, is normally sequestered inside the cell, particularly into mitochondria. However, upon cell stress, as well as during carcinogenesis, the chaperonin becomes exposed on the cell surface (sf-Hsp60) and/or is secreted from cells into the extracellular space and circulation. Reports in the literature on circulating Hsp and anti-Hsp antibodies are in many cases short on detai…

lcsh:Immunologic diseases. Allergyanimal structuresImmunologyCardiovascular Disorders/Heart FailurePublic Health and Epidemiology/Infectious DiseasesChlamydia trachomatisPathology/Immunologychemical and pharmacologic phenomenaReviewmedicine.disease_causecomplex mixturesMicrobiologyAutoimmune DiseasesInfectious Diseases/Bacterial InfectionsPathogenesisImmune systemImmunityVirologyGeneticsmedicineAnimalsHumansImmunology/Cellular Microbiology and Pathogenesislcsh:QH301-705.5Molecular BiologyRheumatology/Autoimmunity Autoimmune and Inflammatory DiseasesAntigens BacterialbiologySettore BIO/16 - Anatomia UmanaMultiple sclerosisfungiAutoantibodyChaperonin 60Chlamydia Infectionsmedicine.diseaseHSP60 ChlamydiaMicrobiology/Immunity to Infectionslcsh:Biology (General)Immunologybiology.proteinParasitologyHSP60AntibodyDiabetes and Endocrinology/Type 1 Diabeteslcsh:RC581-607Chlamydia trachomatisPLoS Pathogens
researchProduct